Home Cart 0 Sign in  

[ CAS No. 58347-48-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 58347-48-1
Chemical Structure| 58347-48-1
Structure of 58347-48-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 58347-48-1 ]

Related Doc. of [ 58347-48-1 ]

Alternatived Products of [ 58347-48-1 ]

Product Details of [ 58347-48-1 ]

CAS No. :58347-48-1 MDL No. :MFCD19313054
Formula : C10H10ClN3O2 Boiling Point : -
Linear Structure Formula :- InChI Key :SSFMULHSDYYZIN-UHFFFAOYSA-N
M.W : 239.66 Pubchem ID :12281648
Synonyms :

Calculated chemistry of [ 58347-48-1 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.3
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 59.05
TPSA : 56.49 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.41 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.32
Log Po/w (XLOGP3) : 1.91
Log Po/w (WLOGP) : 1.87
Log Po/w (MLOGP) : 1.75
Log Po/w (SILICOS-IT) : 1.69
Consensus Log Po/w : 1.91

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.75
Solubility : 0.429 mg/ml ; 0.00179 mol/l
Class : Soluble
Log S (Ali) : -2.72
Solubility : 0.457 mg/ml ; 0.00191 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.21
Solubility : 0.149 mg/ml ; 0.000624 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.37

Safety of [ 58347-48-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 58347-48-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 58347-48-1 ]
  • Downstream synthetic route of [ 58347-48-1 ]

[ 58347-48-1 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 58347-55-0 ]
  • [ 58347-48-1 ]
YieldReaction ConditionsOperation in experiment
21% at 95℃; for 1 h; A solution of ethyl 7-hydroxy-5-methylpyrazolo[l,5-a]pyrimidine-3-carboxylate(4.4 g, 20 mmol) in POCI3(30 mL) was stirred at 95 °C for 1 h and concentrated in vacuo. The residue was dissolved in EtOAc (20 mL) and basified with sat. aHC03 solution (20 mL) to pH~7. The resulting mixture was separated, and the aqueous phase was extracted with EtOAc (15 mL x 3). The combined organic phases were dried over anhydrous Na2S04and filtered. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography (PE/EA; 1 : 1) to give ethyl 7-chloro-5-methylpyrazolo[l,5-a]pyrimidine-3- carboxylate (1.0 g, 21percent) as a white solid. LC-MS m/z: 239.0 [M+H , Purity (254 nm): >82percent, tR = 1.55 min.
Reference: [1] Patent: WO2016/73895, 2016, A1, . Location in patent: Paragraph 00317
[2] Patent: WO2016/209749, 2016, A1, . Location in patent: Page/Page column 45
[3] Patent: WO2017/176960, 2017, A1, . Location in patent: Paragraph 00292
  • 2
  • [ 77493-86-8 ]
  • [ 58347-48-1 ]
Reference: [1] Journal of Medicinal Chemistry, 1981, vol. 24, # 5, p. 610 - 613
  • 3
  • [ 1260243-04-6 ]
  • [ 58347-48-1 ]
Reference: [1] Journal of Medicinal Chemistry, 1981, vol. 24, # 5, p. 610 - 613
  • 4
  • [ 6994-25-8 ]
  • [ 58347-48-1 ]
Reference: [1] Patent: WO2016/73895, 2016, A1,
[2] Patent: WO2017/176960, 2017, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 58347-48-1 ]

Chlorides

Chemical Structure| 223141-46-6

[ 223141-46-6 ]

Ethyl 7-chloro-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxylate

Similarity: 0.92

Chemical Structure| 1053656-37-3

[ 1053656-37-3 ]

Methyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate

Similarity: 0.84

Chemical Structure| 61098-37-1

[ 61098-37-1 ]

Ethyl 7-chloropyrazolo[1,5-a]pyrimidine-5-carboxylate

Similarity: 0.83

Chemical Structure| 1224944-77-7

[ 1224944-77-7 ]

Ethyl 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylate

Similarity: 0.75

Chemical Structure| 1224944-51-7

[ 1224944-51-7 ]

Methyl 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylate

Similarity: 0.74

Esters

Chemical Structure| 223141-46-6

[ 223141-46-6 ]

Ethyl 7-chloro-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxylate

Similarity: 0.92

Chemical Structure| 1053656-37-3

[ 1053656-37-3 ]

Methyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate

Similarity: 0.84

Chemical Structure| 61098-37-1

[ 61098-37-1 ]

Ethyl 7-chloropyrazolo[1,5-a]pyrimidine-5-carboxylate

Similarity: 0.83

Chemical Structure| 115932-00-8

[ 115932-00-8 ]

Ethyl pyrazolo[1,5-a]pyrimidine-3-carboxylate

Similarity: 0.79

Chemical Structure| 1436686-17-7

[ 1436686-17-7 ]

Ethyl 5-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate

Similarity: 0.76

Related Parent Nucleus of
[ 58347-48-1 ]

Other Aromatic Heterocycles

Chemical Structure| 223141-46-6

[ 223141-46-6 ]

Ethyl 7-chloro-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxylate

Similarity: 0.92

Chemical Structure| 1053656-37-3

[ 1053656-37-3 ]

Methyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate

Similarity: 0.84

Chemical Structure| 61098-37-1

[ 61098-37-1 ]

Ethyl 7-chloropyrazolo[1,5-a]pyrimidine-5-carboxylate

Similarity: 0.83

Chemical Structure| 115932-00-8

[ 115932-00-8 ]

Ethyl pyrazolo[1,5-a]pyrimidine-3-carboxylate

Similarity: 0.79

Chemical Structure| 739364-95-5

[ 739364-95-5 ]

2-Methylpyrazolo[1,5-a]pyrimidine-6-carboxylic acid

Similarity: 0.76